Boc-S-benzyl-L-cysteine

Boc-S-benzyl-L-cysteine is a Boc-protected L-cysteine derivative featuring a thioether side chain (S-benzyl) that preserves the cysteine carbon framework while masking thiol reactivity, alongside a tert-butoxycarbonyl (Boc) group on the amino function and a carboxylic acid handle suitable for further conversion. The stereogenic center at the alpha carbon is retained in the L-configuration, enabling stereochemically consistent peptide coupling and downstream fragment assembly. The Boc carbamate can be removed under standard acidolysis conditions to reveal an amine for amide bond formation, while the thioether can participate in controlled sulfur chemistry or be converted into more reactive sulfur functionalities when required. As a chiral, N-protected amino acid derivative with a protected sulfur motif, it functions as a practical intermediate for cysteine-containing peptide building blocks and for synthetic routes that require orthogonal protection strategies.

1. Peptide Synthesis

Boc-S-benzyl-L-cysteine is used in peptide synthesis workflows where cysteine residues are incorporated with orthogonal protection logic, pairing an N-Boc group for amide coupling with an S-benzyl thioether that avoids premature thiol side reactions during chain assembly. The carboxylic acid and Boc-protected amine enable standard peptide coupling chemistry after activation of the acid, while Boc deprotection can be timed to match the stepwise construction of peptide bonds. The thioether sulfur provides a chemically stable handle that can be retained through multiple coupling/deprotection cycles, supporting the preparation of cysteine-containing sequences for biochemical research and material-scaffold peptides. Downstream processing can convert the sulfur motif into alternative cysteine-reactive forms, supporting generation of peptide analogs and sulfur-functionalized derivatives.

2. Side-Chain Functionalization

Boc-S-benzyl-L-cysteine supports side-chain functionalization strategies in synthetic organic chemistry and chemical biology, leveraging the sulfur-containing thioether as a protected sulfur equivalent relative to free thiols. The benzyl-thioether substituent can be transformed into other sulfur oxidation states or reactivity profiles under controlled conditions, enabling access to sulfoxide/sulfone motifs or thiol-like intermediates after selective deprotection or sulfur functional group interconversion. The retained L-stereochemistry and Boc-protected nitrogen allow the compound to be carried through multistep derivatization sequences without racemization at the alpha center. Resulting sulfur-functionalized amino acid derivatives can then be used to build peptidomimetics, conjugation-ready intermediates, and scaffold fragments for structure-activity relationship studies.

3. Chemical Biology Conjugation

Boc-S-benzyl-L-cysteine is suitable for chemical biology applications that require cysteine-compatible conjugation chemistry while maintaining orthogonal protection during synthesis of labeling reagents or probe precursors. The protected amine (Boc) and carboxyl group enable conversion into activated amino acid derivatives that can be assembled into larger constructs, while the S-benzyl thioether can be carried through assembly steps to reduce uncontrolled oxidation or disulfide formation. The L-cysteine backbone stereochemistry supports consistent recognition in peptide-based probes and can be used to generate defined thioether or thiol-derived conjugation handles after controlled sulfur activation. Downstream utility includes preparation of peptide conjugates, probe fragments, and molecular tools used for studying protein interactions and biomolecular labeling patterns.

4. Process Chemistry Intermediate

Boc-S-benzyl-L-cysteine is applied as a manufacturing-oriented intermediate in fine chemical synthesis and process chemistry where stable protection of both the amino group and the sulfur functionality is required for reproducible downstream transformations. The Boc carbamate provides a predictable N-protection strategy that can be removed on demand to expose an amine for coupling, while the S-benzyl thioether reduces thiol oxidation and side reactions during handling and scale-up. The defined stereochemistry at the alpha carbon supports stereochemical integrity across multi-step sequences, including conversion to activated acids, peptide building blocks, or further protected derivatives. The compound can therefore serve in industrial routes that target cysteine-containing intermediates for peptide manufacturing, specialty chemical production, and controlled generation of sulfur-functional amino acid derivatives.

5. Pharmaceutical Manufacturing

Boc-S-benzyl-L-cysteine can be incorporated into pharmaceutical manufacturing supply chains for peptide and peptidomimetic intermediate preparation where cysteine residues must be introduced with controlled protection patterns. The N-Boc protection and carboxyl functionality enable sequential processing toward peptide-grade building blocks, while the thioether sulfur motif helps manage reactivity during purification and coupling operations. The L-configuration supports stereodefined incorporation into larger fragments, aligning with manufacturing needs for consistent structure in drug-like peptide analogs and related research materials. Downstream steps can convert the sulfur functionality into forms compatible with final API-relevant scaffolds or analytical standards used to verify identity and structure in peptide-based production contexts.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics